We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Histone Deacetylase 3 Critical in Maintaining Healthy Intestinal Function

By LabMedica International staff writers
Posted on 11 Nov 2013
A team of molecular microbiologists have found that the enzyme HDAC3 (histone deacetylase 3) in intestinal epithelial cells regulates the relationship between commensal bacteria and mammalian intestine physiology.

Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. More...
Histone acetylation and deacetylation alter chromosome structure and affect transcription factor access to DNA. HDAC3 represses transcription when tethered to a promoter. This protein can also down-regulate p53 function and thus modulate cell growth and apoptosis. The HDAC3 gene is regarded as a potential tumor suppressor gene.

Investigators at the University of Pennsylvania (Philadelphia, USA) examined the role of HDAC3 in maintaining a healthy symbiotic relationship between the intestinal tract and its mixture of commensal bacteria—the microbiota.

To this end, the investigators genetically engineered a line of mice that lacked HDAC3 specifically in the intestinal epithelium. They found that these animals exhibited extensive dysregulation of gene expression, including decreased basal expression of genes associated with antimicrobial defense. When housed under normal laboratory conditions, the genetically engineered mice demonstrated loss of Paneth cells (which secrete antibacterial compounds into the lumen of the intestinal gland, thereby contributing to maintenance of the gastrointestinal barrier), impaired gastrointestinal function, and alterations in the composition of intestinal commensal bacteria. In addition, HDAC3-deficient mice showed significantly increased susceptibility to intestinal damage and inflammation.

Normal gastrointestinal behavior was maintained if the HDAC3-deficient mice were raised in a germ-free environment so that they lacked commensal bacteria.

“There is a fundamental change in the relationship between commensal bacteria and their mammalian hosts following deletion of HDAC3 in the intestine,” said senior author Dr. David Artis, associate professor of microbiology at the University of Pennsylvania. “The implication is that intestinal expression of HDAC3 is an essential component of how mammals regulate the relationship between commensal bacteria and normal, healthy intestinal function. Obviously more has to be done, but it is clear that this is a pathway that is of significant interest as we continue to define how mammals have coevolved with beneficial microbes.”

The study was published in the November 3, 2013, online edition of the journal Nature.

Related Links:

University of Pennsylvania



New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Informatics Platform
CLARION™
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.